ArticleFrontiers in veterinary science2026
Effects of a single-cell protein source from
Article in Frontiers in veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Current Single-cell Proteins as Ingredients: Functions, Challenges, and Regulatory Frameworks.Journal of microbiology and biotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: This study aimed to evaluate the effects of a single-cell protein (SCP) source from Materials and methods: Five extruded diets containing 0, 4, 8, 12, and 16% of SCP were manufactured. To isolate the metabolizable energy (ME) and the ATTD of the SCP, an additional test diet was manufactured containing 80% of the 0% diet and 20% of SCP. In Experiment I, 15 adult Beagle dogs were distributed in a randomized block design with 5 diets (0 to 16% SCP) and two periods of 21 days each, totaling 6 repetitions/treatment. In Experiment II, for the palatability test, 16 adult dogs were used, comparing the diets: 0 vs. 4% SCP; 0% vs. 8% SCP; and 4% vs. 16% SCP. In Experiment III, the SCP digestibility was estimated by the substitution method with 12 adult Beagle dogs. Results: The SCP presented ATTD of dry matter (DM) = 64.3%; ATTD of crude protein = 83.9%; ATTD of acid-hydrolyzed ether extract = 78.3%; and ME of 3843.3 kcal/kg. The ATTD of DM, organic matter, gross energy and the ME of the diets decreased linearly as the dietary inclusion of SCP increased (0 to 16% SCP; Conclusion: These results demonstrate that the dietary inclusion of 4 and 8% SCP promotes less impact on diet digestibility and may beneficially modulate the fecal microbiome and its metabolites in dogs, without affecting diet palatability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.